Dr. Axe Wire · Study decoded · health

Breast Milk Carries 10 to 20 Times More of a Brain-Linked Fat Than Animal Milks

A lab analysis found breast milk carries far more of two fat compounds tied to infant brain and gut development than six animal milks.

By Dr. Josh Axe · November 4, 2026 · 1 source · Watch

Photo: Pexels

Human breast milk contains 10 to 20 times more of a fat-signaling compound called GM3 than milk from six farm and working animals, according to a lab analysis published October 24, 2026 in Food Chemistry.

26GM3 types found

10-20xmore GM3

25regional markers

4China regions

Researchers used two mass spectrometry methods, UPLC-Q-TOF-MS and UPLC-QQQ-MS/MS, to map two fat-signaling compounds, GM3 and GD3, in breast milk from four regions of China (Heilongjiang, Shanxi, Zunyi, Qingdao) across three stages of breastfeeding, comparing it with milk from camels, cows, buffalo, sheep, yak and horses. They identified 26 GM3 types and 12 GD3 types in human milk, built from fat chains 12 to 26 carbons long. Human milk carried 10 to 20 times more GM3 than any animal milk, plus a unique concentration of longer fat chains (22 to 24 carbons); the ruminant milks (cow, buffalo, sheep and yak) were dominated by a shorter 16-carbon GD3 type instead. Milk also changed over time: early milk (colostrum) had a highly varied mix, while later milk became enriched with the longer-chain types. Comparing the four regions turned up 25 location-linked markers, with GD3 most sensitive to region.

Gangliosides sit in cell membranes and help nerve cells communicate and the gut lining mature, which is why researchers track their levels in milk fed to infants. The authors state their findings provide a benchmark for engineering infant formula that better matches human milk's fat composition.

A 10- to 20-fold gap in GM3 is large for a nutrient formula makers already try to match. The authors frame this as a reference map of compositional differences, not proof that matching these fat chains changes a baby's brain or gut development.

10-20fold higher GM3

How much more of the fat-signaling compound GM3 human breast milk had compared with camel, cow, buffalo, sheep, yak and horse milk

Food Chemistry, 2026, Yang et al.

This is chemical profiling of milk samples using mass spectrometry, not a feeding trial, so it does not test infant outcomes. Regional comparisons covered only four areas of China, and the animal-milk comparison covered only six species; linking these differences to measured developmental outcomes is the logical next step.

Dr. Axe’s Take

A 10- to 20-fold gap in this brain-building fat tells me breast milk is not a fixed recipe, it is a living formula that shifts its fat profile as a baby grows, loading up on longer-chain fats as feeding matures. For nursing mothers, I would prioritize whole-food fats, wild-caught fish, pastured eggs and olive oil, since what you eat shapes what shows up in your milk. For parents using formula, look for one made with milk fat globule membrane (MFGM), the part of milk that naturally carries these fats.

— Dr. Axe

Take the Cellular Health Quiz →

Study summary

Who: Human breast milk from four regions of China across three lactation stages, compared with camel, cow, buffalo, sheep, yak and horse milk.
Design: Lab chemical profiling using UPLC-Q-TOF-MS and UPLC-QQQ-MS/MS to measure two ganglioside compounds, GM3 and GD3.
Dose: Not applicable; this was a compositional analysis, not an intervention.
Primary result: Human milk showed 10 to 20 times higher GM3 than all six animal milks, with 26 GM3 types and 12 GD3 types identified.
Secondary: Mature human milk became enriched with very-long-chain fat types (22 and 24 carbons) versus more varied colostrum; 25 markers differed across the four regions, with GD3 most region-sensitive; ruminant milks were dominated by a shorter 16-carbon GD3 type.
Funding / conflicts: Funders listed in the journal record: National Institute of Metrology China; National Key Research and Development Program of China Stem Cell and Translational Research. Competing interests: The authors declare no competing interests.
Date: Oct 24, 2026